Abstract:RNA editing offers the opportunity to introduce either stable or transient modifications to nucleic acid sequence without permanent off-target effects, but installation of arbitrary edits into the transcriptome is currently infeasible. Here, we describe Programmable RNA Editing & Cleavage for Insertion, Substitution, and Erasure (PRECISE), a versatile RNA editing method for writing RNA of arbitrary length and sequence into existing pre-mRNAs via 5′ or 3′ trans-splicing. In trans-splicing, an exogenous template is introduced to compete with the endogenous pre-mRNA, allowing for replacement of upstream or downstream exon sequence. Using Cas7-11 cleavage of pre-mRNAs to bias towards editing outcomes, we boost the efficiency of RNA trans-splicing by 10–100 fold, achieving editing rates between 5–50% and 85% on endogenous and reporter transcripts, respectively, while maintaining high-fidelity. We demonstrate PRECISE editing across 11 distinct endogenous transcripts of widely varying expression levels, showcasing more than 50 types of edits, including all 12 possible transversions and transitions, insertions ranging from 1 to 1,863 nucleotides, and deletions. We show high efficiency replacement of exon 4 of MECP2, addressing most mutations that drive the Rett Syndrome; editing of SHANK3 transcripts, a gene involved in Autism; and replacement of exon 1 of HTT, removing the hallmark repeat expansions of Huntington′s disease. Whole transcriptome sequencing reveals the high precision of PRECISE editing and lack of off-target trans-splicing activity. Furthermore, we combine payload engineering and ribozymes for protein-free, high-efficiency trans-splicing, with demonstrated efficiency in editing HTT exon 1 via AAV delivery. We show that the high activity of PRECISE editing enables editing in non-dividing neurons and patient-derived Huntington’s disease fibroblasts. PRECISE editing markedly broadens the scope of genetic editing, is straightforward to deliver over existing gene editing tools like prime editing, lacks permanent off-targets, and can enable any type of genetic edit large or small, including edits not otherwise possible with existing RNA base editors, widening the spectrum of addressable diseases.

Rewriting endogenous human transcripts with -splicing

Programmable RNA writing with trans-splicing

Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing

RNA Exon Editing: Splicing the way to treat human diseases

SPLICER: A Highly Efficient Base Editing Toolbox That Enables Therapeutic Exon Skipping

A CRISPR-dCas13 RNA-editing tool to study alternative splicing

“A CRISPR-dCas13 RNA-editing tool to study alternative splicing”

CRISPR-dCas13d-based deep screening of proximal and distal splicing-regulatory elements

Splicing Noncoding RNAs from the Inside Out

CRISPR artificial splicing factors

Repair of CRISPR-guided RNA breaks enables site-specific RNA excision in human cells

High-fidelity, efficient, and reversible labeling of endogenous proteins using CRISPR-based designer exon insertion

An enhanced Eco1 retron editor enables precision genome engineering in human cells from a single-copy integrated lentivirus

Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing

Construction of A Versatile, Programmable RNA-binding Protein using Designer PPR Proteins and Its Application for Splicing Control in Mammalian Cells

RNA editing with CRISPR

The human splicing code reveals new insights into the genetic determinants of disease

Long-read RNA-seq demarcates and directed alternative RNA splicing

Precise transcript targeting by CRISPR-Csm complexes

Transcriptome sequencing suggests that pre-mRNA splicing counteracts widespread intronic cleavage and polyadenylation